DNA topoisomerase II inhibitors (PTC Therapeutics)

N/A

Report date: 2025/01/26 19:18:45
NME

Base Information

Drug NameDNA topoisomerase II inhibitors (PTC Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTopoisomerase II inhibitors
TargetsTopoisomerase II
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPtc Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPtc Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A